Ittai Harel is a managing general partner at Pitango Venture Capital, specialized in early-stage and growth venture capital investments in the health-IT, mobile health, medical devices, diagnostics, and drug development industries. Harel studied at the MIT Sloan School of Management and Ben-Gurion University of the Negev, earning an MSc in management and marketing and a BSc in Chemical Engineering and Biotechnology. He has served as director and observer on the board of directors for several companies, such as Connie Health, ImmuneID, Homethrive, TScan Therapeutics, DouxMatok, CLEW, and Medisafe Medication Adherence Platform. Harel is skilled in general management, marketing, and product management, and has experience in M&A, licensing, and structuring commercial and development joint ventures. He is known for his ability to take organizations from development to commercialization.